跳至主要内容
临床试验/NCT03837379
NCT03837379已完成不适用

Development and Testing of a Depression-Specific Behavioral Activation Mobile App Paired With Nicotine Replacement Therapy Sampling for Smoking Cessation Treatment Via Primary Care

Medical University of South Carolina2 个研究点 分布在 1 个国家目标入组 164 人开始时间: 2020年6月22日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
164
试验地点
2
主要终点
7 Day Point Prevalence Abstinence

研究概览

简要总结

The goal of this work is to develop, systematically evaluate, and clinically test an integrated cessation intervention comprised of a depression-specific Behavioral Activation (BA) for cessation mobile app ("Goal2Quit") packaged with nicotine replacement therapy (NRT) sampling. This integrated intervention will address the need for an easily disseminable, evidence-based, depression-specific cessation intervention for delivery via primary care.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Current elevated depressive symptoms defined as a score of > 10 (at least mild depression) on the Patient Health Questionnaire-8 (PHQ-8)
  • Current smoking, defined as smoking 10+ cigarettes/day, for 25+ days out of the last 30, for the last 6+ months
  • Ownership of an Android or iOS smartphone
  • Possess a valid e-mail address that is checked daily to access follow-up assessments
  • English fluency

排除标准

  • Contraindications for NRT (pregnancy/intention to become pregnant/breastfeeding, recent cardiovascular trauma/uncontrolled hypertension) - Severe visual impairment, which may limit ability to utilize an app

结局指标

主要结局

7 Day Point Prevalence Abstinence

时间窗: From 7 days preceding the 12-week follow-up assessment through the 12-week follow-up assessment.

Patients will self report smoking status (yes/no) for the seven days preceding the 12-week follow-up assessment. The data reported is based on the participants that reported yes.

次要结局

  • Mean Score of Depressive Symptoms(Change in BDI from baseline to Week 12)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Jennifer Dahne

Assistant Professor

Medical University of South Carolina

研究点 (2)

Loading locations...

相似试验